DYN
Dyne Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$18.54
+2.69%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 83.07x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.93x
- Price / sales
- —
- Price / cash flow
- -7.24x
Enterprise value
- Enterprise value
- $2.6B
- EV / sales
- —
- EV / EBITDA
- -5.21x
- EV / EBIT
- -4.81x
- Market cap
- $3.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026